1. Ai HH, Zhou ZL, Sun LG, Yang MT, Li W, Yu CL, et al. 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol negatively regulates activation of STAT3 and ERK pathways and exhibits anti-cancer effects in HepG2 cells. Apoptosis. 2017;22:1404–18.
2. Alowaidi F, Hashimi SM, Nguyen M, Meshram M, Alqurashi N, Cavanagh BL, et al. Investigating the role of CRIPTO-1 (TDGF-1) in glioblastoma multiforme U87 cell line. J Cell Biochem. 2018.
3. Bianco C, Strizzi L, Mancino M, Rehman A, Hamada S, Watanabe K, et al. Identification of cripto-1 as a novel serologic marker for breast and colon cancer. Clin Cancer Res. 2006;12:5158–64.
4. Bianco C, Castro NP, Baraty C, Rollman K, Held N, Rangel MC, et al. Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells. J Cell Physiol. 2013;228:1174–88.
5. De Luca A, Casamassimi A, Selvam MP, Losito S, Ciardiello F, Agrawal S, et al. EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells. Int J Cancer. 1999;80:589–94.